Myelodysplastic Syndrome Updated.
Hasserjian RP.
Pathobiology. 2019;86(1):7-13. doi: 10.1159/000489702. Epub 2018 Jul 24.
Childhood Myelodysplastic Syndrome.
Chisholm KM, Bohling SD.
Clin Lab Med. 2023 Dec;43(4):639-655. doi: 10.1016/j.cll.2023.06.005. Epub 2023 Aug 7.
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome.
Battaglia MR, Cannova J, Madero-Marroquin R, Patel AA.
Curr Treat Options Oncol. 2024 Jun;25(6):752-768. doi: 10.1007/s11864-024-01217-0. Epub 2024 May 30.
Myelodysplastic syndrome.
Nakao S, Deeg HJ, Ishikawa T, Marsh J, List A, Tomonaga M.
Int J Hematol. 2005 Dec;82(5):412-6. doi: 10.1532/IJH97.05139.
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes - Advances in treatment.
McCullough KB, Patnaik MM.
Best Pract Res Clin Haematol. 2020 Jun;33(2):101130. doi: 10.1016/j.beha.2019.101130. Epub 2019 Dec 3.
Myelodysplastic syndrome.
Legare RD, Gilliland DG.
Curr Opin Hematol. 1995 Jul;2(4):283-92. doi: 10.1097/00062752-199502040-00008.
Therapy-related myelodysplastic syndrome.
Candelaria M, Dueñas-Gonzalez A.
Expert Opin Drug Saf. 2015 May;14(5):655-65. doi: 10.1517/14740338.2015.1014340. Epub 2015 Feb 12.
EnvIRONmental Aspects in Myelodysplastic Syndrome.
Petzer V, Theurl I, Weiss G, Wolf D.
Int J Mol Sci. 2021 May 14;22(10):5202. doi: 10.3390/ijms22105202.
The myelodysplastic syndrome.
Galton DA.
BMJ. 1989 Sep 2;299(6699):582. doi: 10.1136/bmj.299.6699.582.
Myelodysplastic syndrome.
Wells RA, Buckstein R, Rezmovitz J.
CMAJ. 2016 Jul 12;188(10):751. doi: 10.1503/cmaj.151077. Epub 2016 Jan 4.
